Peptide Reports

Tesamorelin

Community Protocol

Tesamorelin

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 5, 10 and 20 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

SetupDiluentConcentrationUnit conversion
5 MG vial – 2 mL exampleAdd 2 mL bacteriostatic water2.5 mg/mLEach U-100 unit = 25 mcg
20 MG vial – 2 mL exampleAdd 2 mL bacteriostatic water10 mg/mLEach U-100 unit = 100 mcg

Syringe Conversion

Reported amount5 MG setup20 MG setup
500 mcg20 units5 units
1 mg40 units10 units
2 mg80 units20 units
3 mg120 units30 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring reportFrequency seenContext in reports
1 mgOnce dailyLower community reports
2 mgOnce dailyPrescription-label-aligned discussions
2-3 mgOnce daily in some reportsHigher experimental use

Observations

  • Community discussions most often centered on visceral-fat reduction, body composition and growth-hormone-axis goals.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • Prescription tesamorelin has indication-specific contraindications and requires monitoring of IGF-1 and glucose; community use is not equivalent.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. Community search: Tesamorelin
  2. PubMed literature search: Tesamorelin